BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Novogene Expands Global Presence with Increased PacBio Revio Fleet for Enhanced Long-Read Sequencing Applications

Novogene aims to strengthen its service offerings in long-read sequencing applications with PacBio latest Revio sequencer. As an early adopter of PacBio Re...

January 10, 2024 | News

GC Cell Initiates Phase 1 Trials for AB-201 Cancer Treatment with Lunit AI Platform

GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) a...

January 09, 2024 | News

The pioneering clinical implementation of Base Editing Therapy for Hemoglobinopathy on a global scale

On January 8, 2024, Shanghai,China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), using innovative transformer Base Editing (tBE...

January 09, 2024 | News

Shanghai Argo Partners with Novartis in Multi-Program RNAi Licensing and Collaboration

- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as wel...

January 08, 2024 | News

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

January 08, 2024 | News

Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna

First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...

January 05, 2024 | News

IASO BIO Partners with Umoja Biopharma for Cell and Gene Therapies

Under the terms of the collaborations, IASO Bio will receive exclusive access to the rapamycin-activated cytokine receptor (RACR™) platform, Umoja's ...

January 04, 2024 | News

Belief BioMed Completes First Dosing in Hemophilia A Trial

BBM-H803 is Belief BioMed's first gene therapy for the treatment of hemophilia A and is the company's second product which has obtained IND approval from t...

January 04, 2024 | News

MediLink Therapeutics Partners with Roche for Oncology Antibody Drug Conjugate

Under the terms of the agreement, MediLink will grant Roche exclusive global rights for the development, manufacturing, and commercialization of MediLink's...

January 03, 2024 | News

Alcresta Therapeutics Receives FDA Clearance for RELiZORB® Cartridge

Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, announced 510(...

January 02, 2024 | News

Biocytogen, CtM Bio Make Strides in TCR-Mimic Antibody Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and CtM Biotech (Shanghai) Co., Ltd ("CtM Bio") jointly announce tha...

January 01, 2024 | News

Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment

--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...

December 29, 2023 | News

Biomedical Innovation Thrives on Resilience and Adaptability: Insights from the HHP I&E Workshop 2023

A notable highlight of the workshop was a thought-provoking panel discussion featuring serial entrepreneurs and scientific founders: Prof Chwee Teck (C.T.)...

December 29, 2023 | News

AstraZeneca Acquires Gracell, Expanding Cell Therapy Goals in Oncology and Autoimmune Diseases.

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceuti...

December 28, 2023 | News

Stay Connected